Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands
Naozumi Ishimaru1, Rieko Arakaki, Fumie Omotehara
1Department of Oral Molecular Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3 Kuramotocho, Tokushima 770-8504, Japan.
Abstract:
Although tissue-specific apoptosis in the exocrine glands in estrogen-deficient mice may contribute to the development of autoimmune exocrinopathy, the molecular mechanism responsible for tissue-specific apoptosis remains obscure. Here we show that RbAp48 overexpression induces p53-mediated apoptosis in the exocrine glands caused by estrogen deficiency. RbAp48-inducible transfectant results in rapid apoptosis with p53 phosphorylation (Ser9) and alpha-fodrin cleavage. Reducing the expression of RbAp48 through small interfering RNA inhibits the apoptosis. Prominent RbAp48 expression with apoptosis was observed in the exocrine glands of C57BL/6 ovariectomized (OVX) mice but not in OVX estrogen receptor alpha(-/-), p53(-/-), and E2F-1(-/-) mice. Indeed, transgenic expression of the RbAp48 gene induced apoptosis in the exocrine glands but not in other organs. These findings indicate that estrogen deficiency initiates p53-mediated apoptosis in the exocrine gland cells through RbAp48 overexpression and exerts a possible gender-based risk of autoimmune exocrinopathy in postmenopausal women.
Insights
Estrogen deficiency causes RbAp48 overexpression, leading to p53-mediated apoptosis in exocrine glands. This mechanism may explain autoimmune exocrinopathy risk in postmenopausal women.
Area of Science:
- Endocrinology
- Molecular Biology
- Immunology
Background:
- Tissue-specific apoptosis in exocrine glands is implicated in autoimmune exocrinopathy.
- The precise molecular mechanisms driving this apoptosis in estrogen deficiency remain unclear.
Purpose of the Study:
- To elucidate the molecular pathway of tissue-specific apoptosis in estrogen-deficient exocrine glands.
- To investigate the role of RbAp48 in estrogen deficiency-induced apoptosis.
Main Methods:
- Utilized RbAp48-inducible transfectants and small interfering RNA (siRNA) to modulate RbAp48 expression.
- Examined p53 phosphorylation (Ser9) and alpha-fodrin cleavage as markers of apoptosis.
- Compared apoptosis in ovariectomized (OVX) wild-type mice with OVX estrogen receptor alpha(-/-), p53(-/-), and E2F-1(-/-) mice.
Main Results:
- RbAp48 overexpression triggered p53-mediated apoptosis in exocrine glands, evidenced by p53 phosphorylation and alpha-fodrin cleavage.
- siRNA-mediated reduction of RbAp48 inhibited this apoptosis.
- Elevated RbAp48 expression and apoptosis were observed in OVX C57BL/6 mice but not in OVX mice lacking estrogen receptor alpha, p53, or E2F-1.
- Transgenic RbAp48 expression induced apoptosis specifically in exocrine glands.
Conclusions:
- Estrogen deficiency induces apoptosis in exocrine gland cells via RbAp48 overexpression and p53 activation.
- This pathway highlights a potential gender-based risk for autoimmune exocrinopathy in postmenopausal women.
Related Concept Videos
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Export of Misfolded Proteins out of the ER

